Dr. Wai Ho Oscar Yeung, Hong Kong
Delta PD-1 expressed m2 macrophages promote liver tumor recurrence after transplantation

Prof. Arno Kornberg, Germany
Serological tumor viability risk index comprising alpha-fetoprotein and C-reactive protein identifies eligible liver transplant patients with hepatocellular carcinoma beyond milan and up-to-seven criteria

Dr. Quirino Lai, Italy
Proposal for a worldwide usable score for the prediction of recurrence and intention-to-treat survival after liver transplantation in patients with hepatocellular cancer: A West-East analysis on 1,903 patients (Video Available)

Dr. Quirino Lai, Italy
Bridging therapies are not detrimental in patients with hepatocellular cancer waiting for liver transplant: A propensity score analysis (Video Available)

Mr. David Ferreras, Spain
Utility of liquid biopsy (CTCs) after liver transplantation in cirrhotic patients with hepatocarcinoma (Video Available)

Dr. Varvara A. Kirchner, United States
East vs West: Predictors of oncologic outcomes following DD and LD liver transplantation for HCC (Video Available)